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ABSTRACT – Context - Ulcerative colitis is an inflammatory bowel disease involving superficial inflammation of the mucosa of the colon, 
rectum, and anus, sometimes including the terminal ileum. When in clinical activity, the disease is characterized by various daily evacuations 
containing blood, mucus and/or pus alternating periods of remission. Objective - To compare nutritional parameters (dietary, biochemical 
and anthropometric) among patients with ulcerative colitis followed up on an outpatient basis over a period of 1 year and during periods 
of intestinal inflammatory activity and remission. Methods - Sixty-five patients were studied over a period of 1 year and divided into two 
groups: group 1 with inflammatory disease activity (n = 24), and group 2 without disease activity (n = 41). Anthropometric measures, 
biochemical parameters, quantitative food intake, and qualitative food frequency were analyzed. Results - A significant reduction in body mass 
index and weight and in the intake of energy, proteins, lipids, calcium, iron and phosphorus was observed in the group with inflammatory 
activity (group 1) when compared to the period of clinical remission. The most affected food groups were cereals, legumes, oils, and fats. 
In contrast, in group 2 significant differences in triceps and sub scapular skin fold thickness, total protein, hemoglobin and hematocrit 
were observed between the first and final visit. Calcium and vitamin B6 intake, as well as the consumption of legumes, meat and eggs, and 
sugar and sweets, was significantly higher than on the first visit. Conclusion: Patients with ulcerative colitis followed up on an outpatient 
basis tend to be well nourished. However, the nutritional aspects studied tend to worsen during the period of inflammatory disease activity.
HEADINGS – Proctocolitis. Nutrition assessment. Risk groups.
INTRODUCTION
Inflammatory bowel diseases (IBD) comprise a 
variety of disorders that result from the continuous 
activation of the immunoinflammatory cascade, whose 
etiology has not been defined in some cases. Classical 
IBD include Crohn’s disease (CD), ulcerative colitis 
(UC), and indeterminate colitis. These diseases are 
chronic and are characterized by alternating periods 
of recurrence and remission(35, 37).
UC is the result of inflammation which is limited to 
the colonic mucosa; the terminal ileum may be involved 
in rare cases(9, 34, 35, 38). In Europe, the incidence of UC is 
approximately 10 to 20 new cases per 100,000/year, with 
a prevalence of 100 to 200 patients/100,000 inhabitants(9, 
29, 30, 35, 40). No epidemiological surveys regarding the 
prevalence of UC in Brazil are available. According to 
Miszputen(35), Brazil is rated as a geographic area of 
low frequency of this disease based on data from the 
World Gastroenterology Organization. Various genetic, 
immunological and environmental factors have been 
associated with UC(9, 37). As an environmental factor, 
diet may contribute to the pathogenesis of this disease, 
but conclusive studies are still lacking(36).
Malnutrition in IBD is multifactorial, with anorexia, 
nausea, unnecessary food restrictions, increased intestinal 
loss of electrolytes, minerals, trace elements and blood, 
increased energy and nutritional requirements (sepsis, 
fever, increased cell turnover), and interaction between 
drugs and nutrients contributing to this condition(2, 13, 14, 
21, 27, 28, 31, 34, 36). Patients with UC are frequently concerned 
that some foods aggravate their gastrointestinal symptoms 
and often modify their diet in an attempt to control 
their symptoms or to prevent recurrence of the disease. 
This becomes significant when the patient reduces or 
avoids certain foods to an extent that may lead to the 
onset of a nutritional deficiency. No epidemiological 
data are available but it is expected that food intake is 
limited during clinical activity and not during remission 
of the disease(14, 26, 31, 36). Among the foods most cited 
in the literature are the limited ingestion of milk and 
its derivatives and fibers, which are often reported to 
be unnecessary, thus resulting in a supply that lacks 
essential nutrients(3, 5, 10, 11, 14, 20, 31, 32, 33, 43).
Nutritional follow-up by nutritionists, gastroenterologists 
and clinicians is considered to be of fundamental 
importance for patients with UC during both the phase 
of remission and of inflammatory activity. 
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The objective of this study was to compare nutritional 
parameters (dietary, biochemical and anthropometric) among 
patients with UC followed up on an outpatient basis over a 
period of 1 year and during periods of intestinal inflammatory 
activity and remission.
METHODS
Eighty-four patients with a diagnosis of UC consecutively 
seen at the IBD outpatient clinic of the Gastroenterology 
Department (Federal University of São Paulo - UNIFESP), 
who were followed up between January 2004 and August 
2006, were included for this prospective study and called 
general population.
Criteria for inclusion were a definitive diagnosis of UC, 
understanding of the food record and agreement to the free 
informed consent form and excluded those with a history of 
surgery (total colectomy), patients with associated chronic 
diseases (neurological disorders, renal failure, liver diseases, 
cancer, and sclerosing cholangitis), and pregnant women.
During the study, 19 subjects (22.62%) were excluded 
because they did not attend the previously scheduled visits 
or because they could not be contacted by telephone or mail 
according to their data reported during the initial interview. 
Sixty-five patients concluded the protocol and were individually 
followed up over a period of 1 year at intervals of 3 months, 
for a total of five visits per patient including the entry visit.
The patients were submitted to the following evaluations 
on all visits: determination of clinical disease activity using 
the Simple Clinical Colitis Activity Index(24, 45), nutritional 
status (anthropometry), dietary assessment (food record and 
food frequency questionnaire) and biochemical tests.
The 65 patients who attended all visits were subdivided 
into two groups based on the disease activity index throughout 
follow-up. Group 1 consisted of patients who presented 
inflammatory activity on some visit during the study period (n = 
24), and group 2, with those who were in remission throughout 
the study (n = 41). In group 1, the variables were analyzed by 
comparing the same patient during recurrence and remission 
of the inflammatory process. In group 2, data from the same 
patient were compared between the first and final visit.
Anthropometric data were collected on all visits as follows:
•	 	 Height	was	measured	with	a	 sliding	bar	attached	 to	a	
scale to the nearest 0.5 cm; 
•	 	 Weight	was	measured	on	a	calibrated	Filizola® scale to 
the nearest 0.1 kg, with the subject barefoot and wearing 
minimal clothing;
•	 	 Body	mass	index	(BMI)	was	calculated	by	dividing	weight	
(kg) by the square of height (m2)(46);
•	 	 Triceps	(TST)	and	subscapular	skinfold	thickness	(SST)	
was measured with a caliper to the nearest 0.1 mm on 
the right arm. Measurements were made in triplicate and 
means were calculated(6, 12);
•	 	 Arm	circumference	(AC)	was	measured	with	metric	tape	
to the nearest 1 cm on the right arm. This parameter was 
used to calculate arm muscle circumference (AMC) and 
arm muscle area (AMA)(6, 12);
•	 	 AMC	was	calculated	by	the	following	formula:	AMC	(cm)	
= (AC (cm) – π) x TST (mm). AMA was calculated by the 
formula AMA (cm2) = (AMC)2/4 π. AMA was corrected 
for bone area by subtracting 6.5 cm2 for women and 10 
cm2 for men aged 18 to 65 years(6, 12). 
The following biochemical parameters were determined: 
albumin(16), hemoglobin and hematocrit(4), total lymphocyte 
count (TLC) calculated based on the percentage of lymphocytes 
and number of  leukocytes using the formula TLC = % 
lymphocytes x leukocytes/100(4), iron, ferritin, total protein(42), 
leukocytes, and lymphocytes(22).
A quantitative food record was kept by the patient for 3 
predetermined days (Sundays, Tuesdays and Thursdays) in 
the same week as the scheduled visit. The mean of the three 
records was used for analysis.
The NUTWIN Nutrition Support Program (2003) developed 
by the Health Informatics Studies Center of UNIFESP/EPM 
was used to calculate the intake of the following nutrients: 
•	 	 Macronutrients:	total	energy	(kcal),	energy	(kcal/kg)	current	
weight, protein (g), total protein/kg current weight, lipids 
(g), carbohydrates (g), and fibers (g).
•	 	 Minerals:	calcium	(mg),	copper	(mg),	iron	(mg),	magnesium	
(mg), manganese (mg), phosphorus (mg), sodium (mg), 
potassium (mg), zinc (mg), folate (µg), and pantothenic 
acid (mg).
•	 	 Vitamins:	vitamin	A	(IU),	vitamin	C	(mg),	thiamine	(vitamin	
B1, mg), riboflavin (vitamin B2, mg), niacin (vitamin B3, 
mg), pyridoxine (vitamin B6, mg), and cobalamine (vitamin 
B12, µg).
A qualitative food frequency questionnaire was applied 
during the visits by the same interviewer. Foods were divided 
into the following groups: milk and its derivatives, cereals, 
legumes, meat and processed derivatives, vegetables, fruits, 
oils and fats, sugar and sweets, oleaginous seeds, and non-
alcoholic beverages.
All procedures adopted were approved by the Ethics 
Committee of UNIFESP (1147/06).
The results obtained for both groups were analyzed 
statistically. Quantitative variables are reported as the mean 
and standard deviation, and qualitative and semiqualitative 
variables are reported as absolute (n) and relative (%) frequency. 
Variables were compared between the same patients using 
the parametric t-test, adopting a level of  significance of 
P<0.05 (α = 5%).
RESULTS
The initial sample (general population) included 84 
patients. The mean (± SD) age was 45.52 ± 11.61 years (range: 
22 to 77, median: 45 years). The mean age at diagnosis was 
37.50 ± 11.71 years (range: 15 to 72, median: 37 years). The 
mean duration of the disease since the definitive diagnosis 
was 8.02 ± 5.81 years. Among the general population, there 
was a predominance of females (65.48%) who had complete 
elementary school (51.19%), were of urban origin (75.0%), had 
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extensive disease (52.38%), and in clinical remission without 
symptoms related to the inflammatory disease (89.29%).
Most anthropometric parameters were lower during the 
disease activity period compared to that of remission (group 
1), with a significant difference for weight and BMI (Table 1). 
In group 2, the anthropometric parameters showed a trend 
towards improvement on the final visit, with a significant 
difference being observed for body adiposity (TST and SST).
As can be seen in Table 2, most mean values of  the 
biochemical parameters tended to be lower during the 
inflammatory activity period, but the differences were not 
significant. In contrast, in group 2 mean values were lower on 
the final appointment when compared to the first one, with 
the difference being significant for total protein, hemoglobin 
and hematocrit.
Nutrient intake (except for manganese) was higher during 
the remission when compared to the period of inflammatory 
recurrence, with a significant difference being observed for 
total energy, protein, lipids, calcium, iron, and phosphorus 
(Table 3). In group 2, nutrient intake was predominantly 
higher on the final visit. This increase was significant for the 
daily intake of calcium and vitamin B6.
Table 4 shows a trend towards improved intake of different 
food groups in group 1 (except of oleaginous seeds) during 
remission when compared to the period of inflammatory 
activity. A significant difference between the two periods was 
observed for the groups of cereals, legumes, and oils and fats. 
An increase in the intake of most food groups was observed 
in group 2 (except for processed meat and oleaginous seeds) 
between the first and final visit (Table 4), with a significant 
difference for legumes, meat, and sugar and sweets.
DISCUSSION
The objective of this study was an abroad investigation 
of the nutritional conditions of patients with UC stratified 
according to activity and remission of the inflammatory process.
The mean age of the patients (45.52 ± 11.61 years, range: 
22 to 77) was similar to that reported by other investigators(8, 
26, 27), although a lower or higher mean age has also been 
observed(18, 19, 23, 25, 39, 44). The mean age at diagnosis (37.5 ± 
11.71 years) was also similar to that reported in the literature 
as the decade of peak incidence of the disease(9, 35, 41) with a 
higher incidence among women (65.48%). A similar incidence 
has been found in other investigations(1, 23, 39, 44), but there are 
studies reporting a male predominance(8, 18, 19, 25, 26).
Among the 84 patients of the general population, 89.29% 
presented remission of inflammation on the first visit(45). 
Twenty-four (36.92%) of the 65 patients studied over the 
period of 1 year manifested reactivation of the inflammatory 
process. Jowett et al.(26) observed disease recurrence in 52% 
at the same period of follow-up. One criticism to the present 
study might be the lack of  endoscopic confirmation of 
inflammatory reactivity. However, the instrument used to 
classify the characteristics of remission and recurrence has 
been validated previously, with the observation of a strong 
correlation between sigmoidoscopy and the clinical score 
used(24, 45).
TABLE 2. Comparison of biochemical parameters between group 1 and group 2 at disease activity period compared to that of remission (group 1) 
and at first and final visit (group 2)
Biochemical parameter
Group 1 Group 2
Activity
(n = 24)
Remission
(n = 24)
P
First visit
(n = 41)
Final visit
(n = 41)
P
Total protein (g/dL) 7.17 ± 11.12 7.27 ± 0.61 0.400 7.58 ± 0.54 7.45 ± 0.43 0.044*
Albumin (g/dL) 4.40 ± 0.36 4.52 ± 0.28 0.152 4.53± 0.28 4.51 ± 0.27 0.509
Iron (µg/dL) 66.71 ± 31.30 73.17 ± 37.99 0.300 89.27± 36.43 84.02 ± 29.73 0.285
Ferritin (ng/dL) 89.71 ± 168.84 92.00 ± 153.00 0.746 74.63± 57.97 75.54 ± 56.22 0.858
Hemoglobin (g/dL) 13.05 ± 1.80 12.94 ± 2.07 0.610 13.41± 1.52 13.04 ± 1.27 0.010*
Hematocrit (%) 38.25 ± 4.83 38.96 ± 5.55 0.617 40.04± 4.20 38.81 ± 3.56 0.002*
Leukocytes (mm³) 7358.33 ± 2721.10 6905.00 ± 1969.43 0.302 6437.07 ± 1994.33 6108.34 ± 2020.25 0.177
Lymphocytes (%) 27.16 ± 11.12 26.91 ± 10.65 0.919 29.93 ± 8.20 30.57 ± 8.95 0.564
TLC (mm³) 1885.87 ± 744.05 1793.84 ± 738.45 0.628 1961.41 ± 937.67 1811.46 ± 619.28 0.309
TLC = total lymphocyte count; * P<0.05 indicates statistical significance
TABLE 1. Comparison of anthropometric parameters between group 1 and group 2 at disease activity period compared to that of remission (group 
1) and at first and final visit (group 2)
Anthropometric parameter
Group 1 Group 2
Activity
(n = 24)
Remission
(n = 24)
P
First visit
(n = 41)
Final visit
(n = 41)
P
Weight (kg) 66.07 ± 14.42 67.33 ± 15.27 0.033* 65.53 ± 11.24 66.38 ± 12.13 0.167
BMI (kg/m²) 25.37 ± 3.32 25.86 ± 3.52 0.025* 24.64 ± 4.15 24.97 ± 4.49 0.157
TST (mm) 21.38 ± 6.22 22.00 ± 7.40 0.466 17.92 ± 7.68 19.95 ± 8.15 0.003*
SST (mm) 25.71 ± 7.83 25.50 ± 7.99 0.689 20.57 ± 8.43 23.76 ± 8.92 <0.001*
AMC (cm) 23.39 ± 3.35 23.50 ± 2.90 0.670 23.88 ± 2.49 23.44 ± 2.45 0.078
AMA (cm²) 37.61 ± 12.33 37.80 ± 10.16 0.845 38.80 ± 8.68 37.16 ± 8.61 0.086
BMI = body mass index; TST = triceps skinfold thickness; SST = scapular skinfold thickness; AMC = arm muscle circumference; AMA = arm muscle area; * P<0.05 indicates statistical significance
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TABLE 4. Comparison of food frequency between group 1 and group 2 at disease activity period compared to that of remission (group 1) and at first 
and final visit (group 2)
Food groups
Group 1 Group 2
Activity
(n = 24)
Remission
(n = 24)
P
First visit
(n = 41)
Final visit
(n = 41)
P
Milk and derivatives 1.08 ± 0.92 1.42 ± 0.90 0.059 1.47 ± 0.91 1.48 ± 0.71 0.905
Cereals 3.06 ± 1.06 3.57 ± 0.90 0.009* 3.37 ± 0.79 3.43 ± 0.76 0.657
Legumes 0.73 ± 0.56 1.23 ± 0.57 0.001* 1.13 ± 0.54 1.35 ± 0.56 0.020*
Meat 1.46 ± 0.59 1.72 ± 0.43 0.079 1.38 ± 0.36 1.52 ± 0.42 0.015*
Processed meat 0.30 ± 0.33 0.36 ± 0.32 0.285 0.22 ± 0.28 0.22 ± 0.21 1.000
Vegetables 1.59 ± 0.77 1.83 ± 0.62 0.089 1.86 ± 0.80 1.87 ± 0.69 0.920
Fruits 1.57 ± 1.01 1.89 ± 1.07 0.125 2.02 ± 1.07 2.06 ± 0.97 0.737
Oils and fats 2.43 ± 0.98 2.86 ± 0.79 0.011* 3.02 ± 0.67 3.06 ± 0.74 0.690
Sugar and sweets 2.02 ± 0.76 2.14 ± 0.70 0.268 2.72 ± 0.70 2.94 ± 0.57 0.029*
Oleaginous seeds 0.07 ± 0.15 0.05 ± 0.15 0.739 0.05 ± 0.11 0.05 ± 0.10 0.623
Beverages 0.85 ± 0.51 0.96 ± 0.55 0.402 1.03 ± 0.56 1.13 ± 0.59 0.344
* P<0.05 indicates statistical significance
TABLE 3. Comparison of food record data between group 1 and group 2 at disease activity period compared to that of remission (group 1) and at 
first and final visit (group 2)
Energy, macro and 
micronutrients
Group 1 Group 2
Activity
(n = 24)
Remission 
(n = 24)
P
First visit
(n = 41)
Final visit
(n = 41)
P
Energy (kcal) 1714.35 ± 575.28 1905.67 ± 501.98 0.033* 1913.49 ± 496.95 2023.29 ± 103.64 0.172
Energy (kcal/kg) 26.31 ± 8.64 28.77 ± 7.55 0.076 30.3 ± 10.00 31.5 ± 9.30 0.324
Protein (g) 80.19 ± 31.12 92.30 ± 33.18 0.037* 91.78 ± 27.08 99.78 ± 25.12 0.091
Protein (g/kg) 1.21 ± 0.41 1.37 ± 0.40 0.092 1.40 ± 0.50 1.60 ± 0.50 0.106
Lipids (g) 54.05 ± 18.21 61.43 ± 20.44 0.045* 60.12 ± 21.91 61.35 ± 19.06 0.773
Carbohydrates (g) 228.82 ± 88.52 248.39 ± 77.90 0.215 255.99 ± 77.15 272.06 ± 92.77 0.236
Fibers (g) 12.44 ± 9.23 12.90 ± 8.27 0.835 12.31 ± 6.48 14.09 ± 8.07 0.085
Calcium (mg) 529.84 ± 285.62 665.76 ± 313.92 0.0048* 594.57 ± 254.50 709.06 ± 278.55 0.017*
Copper (mg) 1.28 ± 0.84 1.33 ± 0.75 0.778 1.50 ± 0.84 1.39 ± 0.64 0.566
Iron (mg) 13.09 ± 5.35 14.85 ± 5.13 0.041* 15.55 ± 5.73 16.09 ± 4.73 0.515
Magnesium (mg) 243.66 ± 97.76 261.08 ± 74.79 0.348 298.58 ± 125.08 289.13 ± 80.60 0.628
Manganese (mg) 2.48 ± 1.59 2.40 ± 1.04 0.768 2.80 ± 1.29 2.94 ± 1.43 0.579
Phosphorus (mg) 1084.46 ± 401.92 1226.47 ± 333.58 0.012* 1303.69 ± 507.86 1344.37 ± 335.22 0.613
Sodium (mg) 3922.94 ± 993.51 4156.43 ± 1044.08 0.102 4166.16 ± 919.11 4103.00 ± 689.44 0.675
Potassium (mg) 2413.95 ± 1053.08 2497.26 ± 699.61 0.642 2756.26 ± 761.89 2959.69 ± 822.12 0.137
Zinc (mg) 10.58 ± 4.84 11.51 ± 4.80 0.240 11.9 ± 3.67 13.13 ± 3.79 0.094
Folate (mcg) 240.62 ± 135.72 265.69 ± 129.46 0.242 326.63 ± 152.42 323.53 ± 123.59 0.889
Pant. acid (mg) 4.42 ± 1.85 4.76 ± 1.43 0.237 4.71 ± 1.48 5.21 ± 1.70 0.089
Vitamin A (IU) 3008.39 ± 1909.20 3342.84 ± 1682.96 0.543 3474.20 ± 1968.30 3132.45 ± 1937.95 0.423
Vitamin C (mg) 83.02 ± 79.73 101.99 ± 77.23 0.330 109.91 ± 91.65 134.86 ± 129.51 0.305
Thiamine (mg) 1.32 ± 0.61 1.40 ± 0.43 0.094 1.55 ± 0.48 1.67 ± 0.53 0.112
Riboflavine (mg) 1.50 ± 0.81 1.72 ± 0.78 0.094 1.56 ± 0.62 1.82 ± 0.77 0.106
Niacine (mg) 20.41 ± 10.33 23.82 ± 10.53 0.149 24.66 ± 14.37 24.71 ± 9.17 0.984
Vitamin B
6
 (mg) 1.63 ± 0.74 1.73 ± 0.58 0.366 1.71 ± 0.43 1.96 ± 0.62 0.017*
Vitamin B
12
 (µg) 3.86 ± 2.18 4.84 ± 2.59 0.099 4.39 ± 2.38 5.55 ± 2.58 0.055
* P<0.05 indicates statistical significance
Anthropometric evaluation of groups 1 and 2 showed that 
the BMI was within the range of eutrophy to overweight, 
indicating that this population tends to be well nourished(46). 
These findings are in agreement with various studies(8, 15, 17, 18, 
23, 39, 44). A significant difference in mean weight and BMI was 
observed in group 1 (Table 1), demonstrating that during an 
outbreak of inflammatory activity rectocolitic patients present 
a significant weight loss and a consequent reduction of BMI. 
However, these alterations were not significant in relation 
to body composition. This nutritional behavior is probably 
due to the recent onset of recurrence, i.e., there are already 
repercussions on body weight but the time is insufficient for 
drastic changes in body composition to be recognized by 
anthropometric measures, parameters that tend to change 
only after dietary deviations for prolonged periods of time. 
Patients of this outpatient clinic who present inflammatory 
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reactivation are free to seek immediate medical care, irrespective 
of scheduled visits. To our knowledge, there are no studies 
comparing the same population of outpatients with UC during 
the periods of activity and remission. Studies have reported 
a body weight loss of patients hospitalized due to recurrence 
of the disease(27). In addition, BMI might be reduced during 
the active phase of IBD(44) or when compared to a group of 
control subjects(17, 18, 23). Similar to the present results, other 
investigators also found no changes that would compromise 
body composition (lean and fat mass) in patients with UC(8, 15, 
18, 23, 27, 39). Physical exercise can improve muscle strength and 
affect body composition. Muscle mass tends to increase and 
fat mass tends to decrease(28). Unfortunately, no information 
regarding physical exercise is available for the present patients. 
However, it seems reasonable to assume that patients with 
UC are physically less active than healthy individuals.
There was no concern regarding the therapeutic regimens 
used by the patients during any of the phases, since the analyses 
included parameters related to the last pre-visit week. However, 
patients who relapsed between visits and sought medical care 
were evaluated on that occasion and transferred to group 
1. In a few cases, the patients spontaneously modified their 
treatment based on past experience and, when attending the 
scheduled visit again in remission, there was no reason for 
their reallocation to group 1.
Corticosteroids are known to stimulate food intake, to 
promote fat deposition and to alter energy expenditure, 
factors that lead to changes in body composition. We did not 
address therapeutic questions in the present series since, to 
our knowledge, there are no conclusive studies investigating 
the effect of  drug treatment on the nutritional status of 
patients with UC(31).
With respect to biochemical analysis, mean total protein, 
albumin, iron, ferritin, hemoglobin, hematocrit, leukocytes and 
lymphocytes were found to be normal in the general population 
and in groups 1 and 2. Similar results have been reported 
in other studies(8, 18, 44). Lower mean albumin, hemoglobin 
and hematocrit values were observed in patients with active 
IBD, but these findings might have been influenced by the 
inclusion of patients with CD in the same group(15). In the 
present study, TLC was recognized to be within normal limits 
in only 38.10% of the general population. Mild lymphocyte 
depletion has been reported in the literature(15). Lower TLC 
is associated with nutritional deficiencies. Values indicating 
lymphocyte depletion as observed in this study might be due 
to the disease itself  or to the continuous use of medications 
such as immunosuppressive agents. 
We observed no significant difference in the levels of 
albumin, a marker widely used for the classification of 
malnutrition, since it reflects the acute phase reaction mediated 
by cytokines during the inflammatory event. However, the 
time interval between the onset of inflammatory activity of 
the disease and albumin measurement has not been correctly 
defined. A study conducted at UNIFESP investigating the 
relationship between albumin and malnutrition in CD found 
no association between these parameters but there was an 
association between disease activity and hypoalbuminemia(7). 
A decline in albumin levels may also be observed in patients 
hospitalized due to recurrence of UC(27). The observation 
of normal biochemical parameters in this study might be 
explained by outpatient conditions of the patients who did 
not require hospitalization and presented good nutritional 
status (in relation to the anthropometric parameters analyzed 
above).
Significant reductions in total protein, hemoglobin 
and hematocrit were observed in group 2 on the final visit. 
Although some of these reductions were significant, values 
remained within normal limits and at good levels.
In group 1, intake reduction of most nutrients was observed 
during disease activity period, when compared to remission 
phase. Significant differences were observed in energy, 
protein, lipids, calcium, iron, and phosphorus intake. To our 
knowledge, there are no studies in the literature evaluating the 
same patient treated on an outpatient basis during the periods 
of disease activity and remission. Nutrient reduction during 
the symptomatic phase has been suggested to be associated 
with anorexia, abdominal pain, dietary beliefs and attempts 
to relieve symptoms(21, 26, 44). In group 2, patients maintained 
their dietary pattern from the first to the final visit, with the 
observation of significant improvement only in the intake of 
calcium and vitamin B6.
Analysis of  the quantitative food frequency questionnaire, 
group 1 showed a reduction in all food groups (except for 
oleaginous seeds), a finding probably related to the factors 
mentioned earlier. The food groups showing a significant 
reduction in group 1 during the inflammatory activity period 
were cereals, legumes, and oils and fats. Reductions in foods 
such as grains, fruits, vegetables, meat and derivatives, milk 
and derivatives, and lipids during active IBD compared to 
the period of  remission have been reported in the literature(15, 
39, 44). We observed no significant qualitative reduction in 
milk consumption and its derivatives or fibers in those 
with active disease compared to the phase of  remission. 
Diet containing adequate amounts of  calcium and vitamin 
D is recommended as a prophylaxis of  osteopenia and 
osteoporosis(14, 26). In group 2, patients presented a significantly 
higher consumption of  legumes, meat and sugar and sweets 
on the final visit. Foods rich in sulfate and sulfur, such as 
meat (especially red meat) and alcohol, have been implicated 
in the recurrence of  UC(25).
It is known that many patients with UC undergo food 
restrictions based on the indication of health care professionals, 
relatives or friends, or based on findings in magazines and 
newspapers. In the present study, it was not possible to 
evaluate the source of  food restriction since the patients 
did not recall it or received numerous instructions and were 
unable to specify them. The present results may reflect a new 
attitude to patients with UC towards health care habits and 
a greater attention to nutrition. 
FINAL CONSIDERATIONS
Although apparently being well nourished, patients with 
UC may present occult deficiencies in different nutrients which 
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are influenced, in part, by a reduced intake of these nutrients. 
A healthy diet with little or no food restriction, depending 
on individual tolerance, should be encouraged in order to 
maintain a healthy nutritional status. Food restrictions may 
produce deficiencies in different elements, and follow-up by 
a team specialized in clinical nutrition is therefore important. 
Further studies in this area are necessary to define the true 
nutritional needs of this population. Dietary beliefs should 
be revised in order to guide healthcare professionals who 
monitor these patients.
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